Works by McDonnell, David P.

Results: 12

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 6, p. 422, doi. 10.1002/hup.1225

By:

McDonnell, David P.;
Kryzhanovskaya, Ludmila A.;
Zhao, Fangyi;
Detke, Holland C.;
Feldman, Peter D.

Publication type:

Article

Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.

Published in:

International Journal of General Medicine, 2012, v. 5, p. 391, doi. 10.2147/IJGM.S29052

By:

Ascher-Svanum, Haya;
Montgomery, William S.;
McDonnell, David P.;
Coleman, Kristina A.;
Feldman, Peter D.

Publication type:

Article

Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis.

Published in:

Psychiatry & Clinical Neurosciences, 2014, v. 68, n. 7, p. 498, doi. 10.1111/pcn.12156

By:

Katagiri, Hideaki;
Tohen, Mauricio;
McDonnell, David P.;
Fujikoshi, Shinji;
Case, Michael;
Kanba, Shigenobu;
Takahashi, Michihiro;
Gomez, Juan‐Carlos

Publication type:

Article

Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatment.

Published in:

International Journal of Methods in Psychiatric Research, 2014, v. 23, n. 4, p. 439, doi. 10.1002/mpr.1443

By:

Detke, Holland C.;
Lauriello, John;
Landry, John;
McDonnell, David P.

Publication type:

Article

Long-Term Safety and Tolerability of Open-Label Olanzapine Long-Acting Injection in the Treatment of Schizophrenia: 190-Week Interim Results.

Published in:

Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 37, doi. 10.4137/CMPsy.S6659

By:

McDonnell, David P.;
Andersen, Scott W.;
Detke, Holland C.;
Zhao, Fangyi;
Watson, Susan B.

Publication type:

Article

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.

Published in:

Neuropsychiatric Disease & Treatment, 2015, v. 11, p. 1349, doi. 10.2147/NDT.S79347

By:

Anand, Ernie;
Berggren, Lovisa;
Deix, Claudia;
Tóth, Ágoston;
McDonnell, David P.

Publication type:

Article

Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.

Published in:

BMC Psychiatry, 2015, v. 15, p. 1, doi. 10.1186/s12888-015-0669-5

By:

Jones, Meghan E.;
Andrews, Jeffrey S.;
Faries, Douglas E.;
Landry, John;
Xu, Jenny;
Detke, Holland C.;
Chhabra-Khanna, Rashna;
McDonnell, David P.

Publication type:

Article

A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection.

Published in:

BMC Psychiatry, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-244X-14-7

By:

Atkins, Susan;
Detke, Holland C.;
McDonnell, David P.;
Case, Michael G.;
Shufang Wang

Publication type:

Article

Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.

Published in:

BMC Psychiatry, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-244X-13-138

By:

Katagiri, Hideaki;
Tohen, Mauricio;
McDonnell, David P.;
Fujikoshi, Shinji;
Case, Michael;
Kanba, Shigenobu;
Takahashi, Michihiro;
Gomez, Juan-Carlos

Publication type:

Article

Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.

Published in:

BMC Psychiatry, 2011, v. 11, n. 1, p. 28, doi. 10.1186/1471-244X-11-28

By:

Hill, Angela L.;
Bin Sun;
Karagianis, Jamie L.;
Watson, Susan B.;
McDonnell, David P.

Publication type:

Article

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.

Published in:

BMC Psychiatry, 2010, v. 10, p. 45, doi. 10.1186/1471-244X-10-45

By:

McDonnell, David P.;
Detke, Holland C.;
Bergstrom, Richard F.;
Kothare, Prajakti;
Johnson, Jason;
Stickelmeyer, Mary;
Sanchez-Felix, Manuel V.;
Sorsaburu, Sebastian;
Mitchell, Malcolm I.

Publication type:

Article

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.

Published in:

BMC Psychiatry, 2010, v. 10, p. 43, doi. 10.1186/1471-244X-10-43

By:

Detke, Holland C.;
McDonnell, David P.;
Brunner, Elizabeth;
Fangyi Zhao;
Sorsaburu, Sebastian;
Stefaniak, Victoria J.;
Corya, Sara A.

Publication type:

Article